To access this element change to forms mode OFF
Grant Award View - GA133345
A safe, effective, and rapidly tuneable SARS-CoV-2 vaccine
GA ID:
GA133345
Agency:
Department of Health and Aged Care
Approval Date:
4-Sep-2020
Publish Date:
27-Oct-2020
Category:
Health and Medical Research
Grant Term:
1-Oct-2020 to 30-Sep-2022
Value (AUD):
$2,999,502.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_COVID-19_Vaccine_Candidate_Research_Grants_R1
Grant Activity:
A safe, effective, and rapidly tuneable SARS-CoV-2 vaccine
Purpose:
In response to the COVID-19 pandemic greater than200 vaccine candidates are in active development and greater than20 in clinical trials. While we hope that these 'first generation' vaccines will be safe and effective, there are sure to be challenges in deploying these vaccines to all parts of the globe, including Australia, in a timely manner. Accordingly, we have developed two vaccine candidates with significant novelty, tempered by realistic deployment imperatives, to be deployed in this global emergency.
GO ID:
GO Title:
MRFF – 2020 COVID-19 Vaccine Candidate Research grant opportunity
Internal Reference ID:
MRF2005846
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA